CALIFORNIA COMPANIES WORK TOGETHER TO MAKE NEW EUA COVID-19 TESTS AVAILABLE IRVINE, Calif., (June 11, 2020) — With the support of Zymo Research products, two California-based companies, Fulgent Genetics located in Temple City and Curative Inc. based in Menlo Park, have received Emergency Use Authorizations from the US Food and Drug Administration for their rRT-PCR tests... Read more
Caption: New qPCRBIO Probe 1-Step Virus Detect. Click images to download. London, UK (11 June 2020) – PCR Biosystems, the UK-based PCR experts, today announced the launch of qPCRBIO Probe 1-Step Virus Detect, a high-concentration 4x RT-qPCR kit designed specifically for ultra-sensitive, high-throughput detection of viral RNA sequences, including SARS-CoV-2. The new kit, which marks the latest... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) is paving the way for large-scale, next-generation sequencing-based (NGS) COVID-19 testing. Today, the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Illumina COVIDSeq™ Test, a high-throughput, sequencing-based, in vitro diagnostic (IVD) workflow enabling the detection of SARS-CoV-2. The end-to-end workflow extends the options... Read more
MINNEAPOLIS, June 11, 2020 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH) today announced that Exosome Diagnostics, a Bio-Techne brand, has established a new partnership with ZERO – The End of Prostate Cancer, the leading national nonprofit organization in the fight against prostate cancer. ZERO advances research, improves the lives of men and families, and inspires action for patients,... Read more
New diagnostic test for MSI in solid tumors can inform physicians on immuno-oncology therapies and can guide treatment decisions for patients with Lynch-associated cancers Leiden, Netherlands and Madison, WI USA. (June 9, 2020) Promega Corporation today announced CE marking for the OncoMate™ MSI Dx Analysis System(OncoMate™ MSI) as a new in vitro diagnostic (IVD) medical device in Europe.... Read more
Agreement calls for identifying IDH gene mutations using Oncomine Precision Assay and the Ion Torrent Genexus System, a new turnkey, next-generation sequencing solution Read more
ANN ARBOR, Mich. June 3, 2020 /PRNewswire/ — Swift Biosciences and Arbor Biosciences, a division of Chiral Technologies, jointly announced a partnership to offer a complete workflow for RNA-Seq library preparation and targeted enrichment of the SARS-CoV-2 genome. An enabling offering for epidemiological research and public health surveillance, the partnership leverages Swift’s patented Adaptase® technology... Read more
Contributing to advanced medical services including COVID-19 fight in Turkey– Delivering various high-technology medical imaging systems to a new large hospital – Read more
ANN ARBOR, Mich. – May 28, 2020 — Swift Biosciences, Inc., a leader in commercialization of DNA and RNA library preparation kits for Next-Generation Sequencing (NGS), has announced the release of its Swift Normalase™ Amplicon Panel (SNAP) SARS-CoV-2 kit. Targeting the full viral genome in a single tube reaction with a rapid 2-hour workflow, Swift’s... Read more